The New Treatment Platform of Subcutaneous TNF Inhibitors in Inflammatory Bowel Disease (Celltrion Healthcare)

Laurent Peyrin-Biroulet  1     Shomron Ben-Horin  2     Silvio Danese  3    
1 Nancy University Hospital Inserm U954 Dept. of Hepato-Gastroenterology
2 University of Tel Aviv, Sheba Medical Center
3 Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute

UEG Week Virtual 2021


Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing